Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by excitingon Jun 03, 2016 10:09am
117 Views
Post# 24931032

RE:RE:Odd

RE:RE:OddLND is not being diluted as per your wish thinking. 3 millions annualized revenue in exchange and probably lot more in the future. I know how a software company is managed. There are 2 major costs before the success comes in. First you need to have a good niche product cause the development cost can be steep high. And that's what LND is paying for. Second you need to spend lots of money to find potential customers. Again it is very cost intensive. RBP has a niche product and LND has the customers. That led me to say RBP will be kind of explosive not in the sense of revenue but rathe in the earnings. What strike me the most in LND is their cost and expense structure are extremely low while their lending business is growing nicely. RBP is even more explosive in the sense their cost structure is even lower. In 18 months LND has 2.4 millions revenues per Qtr and 1.4 millions earnings my projection is within the same timeline RBP would reach the same revenue but in term of earning it should be a lot more higher. And we all know the multiple for a successful software in lot higher than for a lending company. That's what LND is paying for and not as the same moron's wish thinking implied. Again time will tell. So far his predictions are all out of whack and on the other hand LND is growing nicely.
Bullboard Posts